ARTA
INO icon

A.R.T. Advisors’s Inovio Pharmaceuticals INO Stock Holding History

A.R.T. Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,482
Closed -$138K – 508
2019
Q4 		$138K Buy
3,482
+283
+9% +$8.52K 0.01% 1198
2019
Q3 		$79K Sell
3,199
-1,124
-26% -$34.2K ﹤0.01% 1280
2019
Q2 		$153K Buy
4,323
+1,949
+82% +$77.4K 0.01% 1147
2019
Q1 		$106K Buy
2,374
+200
+9% +$10.1K 0.01% 1165
2018
Q4 		$104K Buy
+2,174
New +$132K 0.01% 1161
2017
Q4 		– Sell
-2,417
Closed -$183K – 1512
2017
Q3 		$183K Sell
2,417
-8,308
-77% -$618K 0.01% 1150
2017
Q2 		$1.01M Buy
+10,725
New +$917K 0.05% 521
2015
Q4 		– Sell
-23,812
Closed -$1.65M – 1581
2015
Q3 		$1.65M Buy
+23,812
New +$2.07M 0.06% 442
2015
Q2 		– Sell
-2,218
Closed -$217K – 1576
2015
Q1 		$217K Buy
+2,218
New +$215K 0.01% 1208
2014
Q4 		– Sell
-13,532
Closed -$1.6M – 1529
2014
Q3 		$1.6M Buy
+13,532
New +$1.69M 0.07% 364
2013
Q4 		– Sell
-968
Closed -$96K – 1371
2013
Q3 		$96K Buy
+968
New +$81.1K 0.01% 1222

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

A.R.T. Advisors's INO Position: Q1 2020 in Review

A.R.T. Advisors sold out of Inovio Pharmaceuticals (INO) in Q1 2020, closing a stake of 3,482 shares — an estimated $138K sold.

A.R.T. Advisors first reported a position in INO in Q3 2013 and held it in 11 quarters. The position peaked at $1.65M in Q3 2015. 158 funds tracked by Wall St. Rank hold INO as of Q1 2020.

  • A.R.T. Advisors reported no remaining Inovio Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 3,482 Inovio Pharmaceuticals shares in Q1 2020, an estimated $138K.
  • A.R.T. Advisors first reported a position in Inovio Pharmaceuticals in Q3 2013 and held it in 11 quarters.
  • A.R.T. Advisors's Inovio Pharmaceuticals position peaked at $1.65M in Q3 2015.
  • 158 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.